1
Geurten, R.J., Struijs, J.N., Elissen, A.M.J., Bilo, H.J.G., van Tilburg, C., Ruwaard, D.
Veröffentlicht in: Geurten , R J , Struijs , J N , Elissen , A M J , Bilo , H J G , van Tilburg , C & Ruwaard , D 2022 , ' Delineating the Type 2 Diabetes Population in the Netherlands Using an All-Payer Claims Database: Specialist Care, Medication Utilization and Expenditures 2016-2018 ' , PharmacoEconomics - open , vol. 6 , no. 2 , pp. 219-229 . https://doi.org/10.1007/s41669-021-00308-0;
2022
Veröffentlicht in: Geurten , R J , Struijs , J N , Elissen , A M J , Bilo , H J G , van Tilburg , C & Ruwaard , D 2022 , ' Delineating the Type 2 Diabetes Population in the Netherlands Using an All-Payer Claims Database: Specialist Care, Medication Utilization and Expenditures 2016-2018 ' , PharmacoEconomics - open , vol. 6 , no. 2 , pp. 219-229 . https://doi.org/10.1007/s41669-021-00308-0;
2022